Neurothera Labs Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Equivalents	1.7	0.12
Cash & Short-Term Investments	1.7	0.12
Cash Growth	1353.85%	-
Accounts Receivable	0.01	0.01
Other Receivables	0.07	0.04
Receivables	0.08	0.05
Inventory	0.08	0.11
Restricted Cash	0.01	0.01
Total Current Assets	1.86	0.29
Other Intangible Assets	1.17	1.48
Total Assets	3.03	1.76
Accounts Payable	0.35	0.02
Accrued Expenses	0.33	0.19
Current Portion of Long-Term Debt	0.36	-
Other Current Liabilities	0.34	0.02
Total Current Liabilities	1.38	0.23
Long-Term Debt	0.58	-
Other Long-Term Liabilities	0.43	-
Total Liabilities	2.39	0.23
Additional Paid-In Capital	25.1	5.56
Retained Earnings	-24.96	-20.84
Comprehensive Income & Other	-	16.06
Total Common Equity	0.13	0.78
Minority Interest	0.51	0.75
Shareholders' Equity	0.65	1.54
Total Liabilities & Equity	3.03	1.76
Total Debt	0.93	-
Net Cash (Debt)	0.77	0.12
Net Cash Growth	555.56%	-
Net Cash Per Share	0.01	0.00
Filing Date Shares Outstanding	84.9	63.3
Total Common Shares Outstanding	84.9	63.3
Working Capital	0.49	0.06
Book Value Per Share	0.00	0.01
Tangible Book Value	-1.04	-0.7
Tangible Book Value Per Share	-0.01	-0.01